In addition, ADRBK2 (upstream regulator of SMO) and CCND2 (Hh downstream target gene) were also significantly elevated in NAFLD rats (Figure 4(b)). This evidence concerns the gene GRK3 and metabolic dysfunction-associated steatotic liver disease.